Literature DB >> 17006648

Expressions of polypeptide: N-acetylgalactosaminyltransferase in leukemia cell lines during 1,25-dihydroxyvitamin D3 induced differentiation.

Hao Qiu1, Xiang-Hong Guo, Jian-Hua Mo, Mei-Fang Jin, Shi-Liang Wu, Hui-Li Chen.   

Abstract

The effect of 1,25-dihydroxyvitamin D3 [1,25(OH)(2)D3] on two leukemia cell lines, K562 and SHI-1, and its relation to the expression of different subtypes of polypeptide: N-acetylgalactosaminyltransferase (pp-GalNAc-T) was studied. With morphological and cell flow-cytometric method, it was found that 1,25(OH)(2)D3 induced the differentiation of both leukemia cell lines toward monocytic lineage, but not affected the cell growth and apoptosis. The expressions of different subtypes of pp-GalNAc-T, the initial glycosyltransferase in O-glycan synthesis, were studied with RT-PCR before and after the treatment of different concentrations of 1,25(OH)(2)D3. Among fourteen subtypes of pp-GalNAc-T (T1 approximately T14), K562 cells obviously expressed pp-GalNAc-T2, T4, T5, T7 (T2 was the highest) and SHI-1 cells apparently expressed pp-GalNAcT1, T2, T3 and T4 (T4 was the highest) only. After K562 cells were treated 1, 25(OH)(2)D3 for 72 h, pp-GalNAc-T2, T4, T5, T7 were increased in a dose dependent manner. In contrast, pp-GalNAc-T1 and T2, especially T1, were up-regulated in SHI-1 cells by 1,25(OH)(2)D3, but T3 was unchanged and T4 was down-regulated. The different alterations of pp-GalNAc-Ts in these two cell lines were probably related to the different structural changes of O-glycans during 1,25(OH)(2)D3 induced differentiation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17006648     DOI: 10.1007/s10719-006-8095-z

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  32 in total

1.  Properties of the K562 cell line derived from a patient with chronic myeloid leukemia.

Authors:  B B Lozzio; C B Lozzio
Journal:  Int J Cancer       Date:  1977-01       Impact factor: 7.396

2.  Enzymatic synthesis of the protein-hexosamine linkage in sheep submaxillary mucin.

Authors:  E J McGuire; S Roseman
Journal:  J Biol Chem       Date:  1967-08-25       Impact factor: 5.157

3.  Functional conservation of subfamilies of putative UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferases in Drosophila, Caenorhabditis elegans, and mammals. One subfamily composed of l(2)35Aa is essential in Drosophila.

Authors:  Tilo Schwientek; Eric P Bennett; Carlos Flores; John Thacker; Martin Hollmann; Celso A Reis; Jane Behrens; Ulla Mandel; Birgit Keck; Mireille A Schäfer; Kim Haselmann; Roman Zubarev; Peter Roepstorff; Joy M Burchell; Joyce Taylor-Papadimitriou; Michael A Hollingsworth; Henrik Clausen
Journal:  J Biol Chem       Date:  2002-03-29       Impact factor: 5.157

Review 4.  Overview of general physiologic features and functions of vitamin D.

Authors:  Hector F DeLuca
Journal:  Am J Clin Nutr       Date:  2004-12       Impact factor: 7.045

5.  Cloning and characterization of a close homologue of human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase-T3, designated GalNAc-T6. Evidence for genetic but not functional redundancy.

Authors:  E P Bennett; H Hassan; U Mandel; M A Hollingsworth; N Akisawa; Y Ikematsu; G Merkx; A G van Kessel; S Olofsson; H Clausen
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

6.  Calcitriol-induced prostate-derived factor: autocrine control of prostate cancer cell growth.

Authors:  Nadja Nazarova; Shengjun Qiao; Olga Golovko; Yan-Ru Lou; Pentti Tuohimaa
Journal:  Int J Cancer       Date:  2004-12-20       Impact factor: 7.396

7.  Inhibition by 1,25 dihydroxyvitamin D3 of chemically induced erythroid differentiation of K562 leukemia cells.

Authors:  D C Moore; D L Carter; A K Bhandal; G P Studzinski
Journal:  Blood       Date:  1991-04-01       Impact factor: 22.113

8.  Cloning of a human UDP-N-acetyl-alpha-D-Galactosamine:polypeptide N-acetylgalactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeat.

Authors:  E P Bennett; H Hassan; U Mandel; E Mirgorodskaya; P Roepstorff; J Burchell; J Taylor-Papadimitriou; M A Hollingsworth; G Merkx; A G van Kessel; H Eiberg; R Steffensen; H Clausen
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

9.  Ligand modulates VDR-Ser/Thr protein phosphatase interaction and p70S6 kinase phosphorylation in a cell-context-dependent manner.

Authors:  David J Bettoun; Jianfen Lu; Berket Khalifa; Ying Yee; William W Chin; Sunil Nagpal
Journal:  J Steroid Biochem Mol Biol       Date:  2004-05       Impact factor: 4.292

10.  Cloning and characterization of a novel UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase, pp-GalNAc-T14.

Authors:  Han Wang; Kouichi Tachibana; Yan Zhang; Hiroko Iwasaki; Akihiko Kameyama; Lamei Cheng; Jian ming Guo; Toru Hiruma; Akira Togayachi; Takashi Kudo; Norihiro Kikuchi; Hisashi Narimatsu
Journal:  Biochem Biophys Res Commun       Date:  2003-01-17       Impact factor: 3.575

View more
  4 in total

1.  PpGalNacT2 participating in vanadium-induced HL-60 cell differentiation.

Authors:  Yuan Gao; You Bin Tu; Yi Guo; Ling Yan Yang; Xiang Hong Guo; Lan Xu; Zheng Rong Xu; Shi Liang Wu
Journal:  Mol Biol Rep       Date:  2010-09-29       Impact factor: 2.316

2.  Expression of β1,3-N-acetylglucosaminyltransferases during differentiation of human acute myeloid leukemia cells.

Authors:  Hao Qiu; Shi-Liang Wu; Xiang-Hong Guo; Hong-Jie Shen; Huan-Ping Zhang; Hui Li Chen
Journal:  Mol Cell Biochem       Date:  2011-07-01       Impact factor: 3.396

3.  Polypeptide N-acetylgalactosaminyltransferase 2 regulates cellular metastasis-associated behavior in gastric cancer.

Authors:  Dong Hua; Li Shen; Lan Xu; Zhi Jiang; Yinghui Zhou; Aihuan Yue; Shitao Zou; Zhihong Cheng; Shiliang Wu
Journal:  Int J Mol Med       Date:  2012-09-18       Impact factor: 4.101

Review 4.  N-acetylgalactosaminyltransferases in cancer.

Authors:  Muhammad Ramzan Manwar Hussain; Daniel C Hoessli; Min Fang
Journal:  Oncotarget       Date:  2016-08-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.